Estados financieros detallados de Galectin Therapeutics Inc. (GALT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $3.68, GALT presenta beneficios negativos (P/E no significativo) y un ROE del 24.44%. La capitalización bursátil es de $242M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $7000 | $1000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$7000 | -$1000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $15.3M | $11.7M | $6.5M | $7.5M | $18.0M | $23.8M | $31.7M | $32.1M | $36.6M | $14.3M |
| Generales y Administrativos | $6.2M | $4.5M | $7.1M | $6.0M | $5.5M | $6.4M | $6.6M | $5.9M | $5.9M | $5.8M |
| Gastos Operativos | $21.5M | $16.2M | $13.6M | $13.4M | $23.4M | $30.2M | $38.4M | $38.1M | $42.4M | $20.1M |
| Beneficio Operativo | -$21.5M | -$16.2M | -$13.6M | -$13.4M | -$23.4M | -$30.2M | -$38.4M | -$38.1M | -$42.4M | -$20.1M |
| EBITDA | -$21.5M | -$16.2M | -$13.6M | -$13.2M | -$23.3M | -$30.0M | -$37.7M | -$38.2M | -$41.5M | -$23.5M |
| Gastos por Intereses | 0 | $12000 | $336000 | $87000 | $87000 | $489000 | $1.0M | $2.8M | $5.5M | $7.3M |
| Beneficio Antes de Impuestos | -$21.4M | -$16.2M | -$13.9M | -$13.3M | -$23.5M | -$30.5M | -$38.8M | -$41.1M | -$47.0M | -$30.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$21.4M | -$16.2M | -$13.9M | -$13.3M | -$23.5M | -$30.5M | -$38.8M | -$41.1M | -$47.0M | -$30.8M |
| BPA | $-0.73 | $-0.46 | $-0.35 | $-0.39 | $-0.41 | $-0.52 | $-0.65 | $-0.74 | $-0.76 | $-0.48 |
| BPA Diluido | $-0.73 | $-0.46 | $-0.35 | $-0.39 | $-0.41 | $-0.52 | $-0.65 | $-0.74 | $-0.76 | $-0.48 |
| Acciones en Circulación (Diluidas) | $29.2M | $35.5M | $39.4M | $52.2M | $57.0M | $58.5M | $59.4M | $60.2M | $62.3M | $63.9M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $15.4M | $3.1M | $8.3M | $47.5M | $27.1M | $39.6M | $18.6M | $25.7M | $15.1M | $17.7M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $15.8M | $3.8M | $8.8M | $48.2M | $29.5M | $41.8M | $20.6M | $27.7M | $17.3M | $19.4M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $53000 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $1000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $15.8M | $4.2M | $9.0M | $48.5M | $29.6M | $41.8M | $21.3M | $28.2M | $17.5M | $19.5M |
| Cuentas por Pagar | $910000 | $608000 | $297000 | $1.7M | $1.3M | $1.8M | $3.9M | $6.4M | $5.7M | $3.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $21.1M | 0 |
| Pasivos Corrientes | $3.8M | $3.0M | $2.1M | $2.8M | $5.4M | $9.0M | $13.0M | $15.7M | $35.4M | $8.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | $29.0M | $39.8M | $71.7M | $85.1M | $133.7M |
| Pasivos Totales | $3.8M | $3.0M | $2.1M | $2.9M | $5.4M | $39.2M | $53.5M | $88.4M | $120.6M | $145.7M |
| Reservas | -$163.7M | -$181.2M | -$196.2M | -$216.4M | -$240.0M | -$270.7M | -$309.6M | -$354.4M | -$401.6M | -$432.5M |
| Patrimonio Neto | $12.0M | $1.2M | $6.9M | $45.6M | $24.2M | $2.6M | -$32.2M | -$60.2M | -$103.1M | -$126.2M |
| Deuda Total | 0 | 0 | 0 | $39000 | $44000 | $29.1M | $39.9M | $71.8M | $106.2M | $133.8M |
| Deuda Neta | -$15.4M | -$3.1M | -$8.3M | -$47.4M | -$27.1M | -$10.6M | $21.3M | $46.1M | $91.1M | $116.0M |
| Capital Circulante | $12.0M | $851000 | $6.7M | $45.4M | $24.1M | $32.8M | $7.5M | $12.0M | -$18.2M | $11.4M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$21.4M | -$16.2M | -$13.9M | -$13.3M | -$23.5M | -$30.5M | -$38.8M | -$41.1M | -$47.0M | -$30.8M |
| Amortizaciones | $7000 | $1000 | 0 | $35000 | $36000 | $41000 | $32000 | $33000 | $37000 | $53000 |
| Compensación en Acciones | $2.5M | $1.1M | $4.4M | $1.7M | $1.8M | $2.1M | $2.9M | $2.3M | $2.4M | $1.7M |
| Cambio en Capital Circulante | $2.5M | -$804000 | -$1.1M | $641000 | $942000 | $3.8M | $5.0M | $4.7M | $2.3M | $609000 |
| Flujo de Caja Operativo | -$16.4M | -$15.9M | -$10.2M | -$10.8M | -$20.6M | -$24.3M | -$31.1M | -$33.0M | -$41.8M | -$23.9M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | -$741000 | -$1.2M | -$915000 | -$394000 | -$137000 | -$171000 | 0 | 0 | -$91000 | 0 |
| Flujo de Caja Libre | -$16.4M | -$15.9M | -$10.2M | -$10.8M | -$20.6M | -$24.3M | -$31.1M | -$33.0M | -$41.8M | -$23.9M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | +24.3% | +14.4% | +4.4% | -76.5% | -30.1% | -27.0% | -5.9% | -14.6% | +34.5% | |
| Crecimiento BPA (anual) | +37.0% | +23.9% | -11.4% | -5.1% | -26.8% | -25.0% | -13.8% | -2.7% | +36.8% | |
| Cambio en Acciones (anual) | +21.6% | +11.0% | +32.5% | +9.2% | +2.6% | +1.5% | +1.3% | +3.6% | +2.6% | |
| Crecimiento FCF (anual) | +3.2% | +35.9% | -6.6% | -89.9% | -18.0% | -27.8% | -6.1% | -26.7% | +42.8% | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.56 | $-0.45 | $-0.26 | $-0.21 | $-0.36 | $-0.42 | $-0.52 | $-0.55 | $-0.67 | $-0.37 |
| Dividendo por Acción | $0.03 | $0.03 | $0.02 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $29.2M | $35.5M | $39.4M | $52.2M | $57.0M | $58.5M | $59.4M | $60.2M | $62.3M | $63.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | 24.44% |
| Rentabilidad sobre capital invertido | -174.29% |
| Rentabilidad sobre activos | -157.87% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | -1.06 |
| Ratio corriente | 2.42 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -32.60 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -1.34 | -7.26 | -9.80 | -7.33 | -5.46 | -3.98 | -1.74 | -2.24 | -1.70 | -8.67 |
| P/VC | 2.38 | 99.45 | 19.60 | 3.28 | 5.28 | 46.31 | -2.08 | -1.66 | -0.78 | -2.11 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ALT · AURA · DMAC · DRTS · DSGN · ENGN · IMAB
Explorar sector: Healthcare · Biotechnology
Más secciones de GALT: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones